Olga V. Makhlynets

Olga V. Makhlynets

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olga V. Makhlynets has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Peptide Hydrogel Responsive to Reactive Oxygen Species and pH for the Protection and Sustained Delivery of Insulin-like Growth Factor 1 in Osteoarthritis Treatment

    by Dona Imanga Upamadi Edirisinghe, Ashmeet Singh, Michael Patrick Seitz, Alireza Jafar Esmaeili, Thalma Kabeyi Orado, Emma Herrero, Jennifer Jankowski, Precious Kemilembe Kairuki, Liam R. Marshall, Era Jain, et al.

    Osteoarthritis (OA) is the leading cause of disability in adults worldwide. This debilitating disease is associated with a relatively high concentration of reactive oxygen species (ROS) and reduced pH in the joints. In this regard, we devised a two-pronged approach to treating OA that combines ROS neutralization and stimuli-responsive drug delivery. Specifically, we developed a series of biocompatible, self-healing short peptide hydrogels that preserve their rheological properties in a wide range of biologically relevant salt concentrations. We evaluated the ROS-responsive release of a cartilage healing promoting growth factor (insulin-like growth factor 1, IGF-1) from these biomaterials. Furthermore, the ROS-responsive peptide hydrogel's ability to sequester ROS can potentially relieve disease-associated symptoms and minimize cell damage. The simplicity and effectiveness of this multistimuli-responsive smart biomaterial suggest promise in OA treatment.


  • Open Access

    Antibacterial and Cytocompatible pH-Responsive Peptide Hydrogel

    by Dona Imanga Upamadi Edirisinghe, Areetha D’souza, Maryam Ramezani, Robert J. Carroll, Quenten Chicón, Cheyene L. Muenzel, Jonathan Soule, Mary Beth Browning Monroe, Alison E. Patteson, Olga V. Makhlynets

    A short peptide, FHHF-11, was designed to change stiffness as a function of pH due to changing degree of protonation of histidines. As pH changes in the physiologically relevant range, G′ was measured at 0 Pa (pH 6) and 50,000 Pa (pH 8). This peptide-based hydrogel is antimicrobial and cytocompatible with skin cells (fibroblasts). It was demonstrated that the incorporation of unnatural AzAla tryptophan analog residue improves the antimicrobial properties of the hydrogel. The material developed can have a practical application and be a paradigm shift in the approach to wound treatment, and it will improve healing outcomes for millions of patients each year.


  • Open Access

    A Simulation Independent Analysis of Single- and Multi-Component cw ESR Spectra

    by Aritro Sinha Roy, Boris Dzikovski, Dependu Dolui, Olga Makhlynets, Arnab Dutta, Madhur Srivastava

    The accurate analysis of continuous-wave electron spin resonance (cw ESR) spectra of biological or organic free-radicals and paramagnetic metal complexes is key to understanding their structure–function relationships and electrochemical properties. The current methods of analysis based on simulations often fail to extract the spectral information accurately. In addition, such analyses are highly sensitive to spectral resolution and artifacts, users’ defined input parameters and spectral complexity. We introduce a simulation-independent spectral analysis approach that enables broader application of ESR. We use a wavelet packet transform-based method for extracting g values and hyperfine (A) constants directly from cw ESR spectra. We show that our method overcomes the challenges associated with simulation-based methods for analyzing poorly/partially resolved and unresolved spectra, which is common in most cases. The accuracy and consistency of the method are demonstrated on a series of experimental spectra of organic radicals and copper–nitrogen complexes. We showed that for a two-component system, the method identifies their individual spectral features even at a relative concentration of 5% for the minor component.


  • Open Access

    A Simulation Independent Analysis of Single- and Multi-Component cw ESR Spectra

    by Aritro Sinha Roy, Boris Dzikovski, Dependu Dolui, Olga V Makhlynets, Arnab Dutta, Madhur Srivastava

    Accurate analysis of continuous-wave electron spin resonance (cw ESR) spectra of biological or organic free-radicals and paramagnetic metal complexes is key to understand their structure-function relationships and electrochemical properties. Current method of analysis based on simulations often fail to extract the spectral information accurately. In addition, such analyses are highly sensitive to spectral resolution and artifacts, users’ defined input parameters and spectral complexity. We introduce a simulation-independent spectral analysis approach that enables broader application of ESR. We use a wavelet packet transform-based method for extracting g values and hyperfine (A) constants directly from cw ESR spectra. We show that our method overcomes the challenges associated with simulation-based methods for analyzing poorly / partially resolved and unresolved spectra, which is a common in most cases. The accuracy and consistency of the method are demonstrated on a series of experimental spectra of organic radicals and copper-nitrogen complexes. We showed that for a two-component system, the method identifies their individual spectral features even at a relative concentration of 5% for the minor component.

  • NMR-guided directed evolution

    by Sagar Bhattacharya, Eleonora G. Margheritis, Katsuya Takahashi, Alona Kulesha, Areetha D’sOuza, Inhye Kim, Jennifer H. Yoon, Jeremy R. H. Tame, Alexander N. Volkov, Olga V. Makhlynets, et al.


  • Open Access

    Peptide hydrogel with self-healing and redox-responsive properties

    by Areetha D’sOuza, Liam R. Marshall, Jennifer Yoon, Alona Kulesha, Dona I. U. Edirisinghe, Siddarth Chandrasekaran, Parth Rathee, Rajeev Prabhakar, Olga V. Makhlynets

    We have rationally designed a peptide that assembles into a redox-responsive, antimicrobial metallohydrogel. The resulting self-healing material can be rapidly reduced by ascorbate under physiological conditions and demonstrates a remarkable 160-fold change in hydrogel stiffness upon reduction. We provide a computational model of the hydrogel, explaining why position of nitrogen in non-natural amino acid pyridyl-alanine results in drastically different gelation properties of peptides with metal ions. Given its antimicrobial and rheological properties, the newly designed hydrogel can be used for removable wound dressing application, addressing a major unmet need in clinical care.


  • Open Access

    NMR-Guided Directed Evolution

    by Ivan Korendovych, Sagar Bhattacharya, Eleanora Margheritis, Katsuya Takahashi, Alona Kulesha, Areetha D'Souza, Inhye Kim, Jeremy Tame, Jennifer Yoon, Alexander Volkov, et al.

    Directed evolution can rapidly achieve dramatic improvements in the properties of a protein or bestow entirely new functions on it. We have discovered a strong correlation between the probability of finding a productive mutation at a particular position of a protein and a chemical shift perturbation in Nuclear Magnetic Resonance spectra upon addition of an inhibitor for the chemical reaction it promotes. In a proof-of-concept study we converted myoglobin, a non-enzymatic protein, into the most active Kemp eliminase reported to date using only three mutations. The observed levels of catalytic efficiency are on par with the levels shown by natural enzymes. This simple approach, that requires no a priori structural or bioinformatic knowledge, is widely applicable and will unleash the full potential of directed evolution.


  • Open Access

    Beneficial Impacts of Incorporating the Non-Natural Amino Acid Azulenyl-Alanine into the Trp-Rich Antimicrobial Peptide buCATHL4B

    by Areetha R. D’souza, Matthew R. Necelis, Alona Kulesha, Gregory A. Caputo, Olga V. Makhlynets

    Antimicrobial peptides (AMPs) present a promising scaffold for the development of potent antimicrobial agents. Substitution of tryptophan by non-natural amino acid Azulenyl-Alanine (AzAla) would allow studying the mechanism of action of AMPs by using unique properties of this amino acid, such as ability to be excited separately from tryptophan in a multi-Trp AMPs and environmental insensitivity. In this work, we investigate the effect of Trp→AzAla substitution in antimicrobial peptide buCATHL4B (contains three Trp side chains). We found that antimicrobial and bactericidal activity of the original peptide was preserved, while cytocompatibility with human cells and proteolytic stability was improved. We envision that AzAla will find applications as a tool for studies of the mechanism of action of AMPs. In addition, incorporation of this non-natural amino acid into AMP sequences could enhance their application properties.


  • Characteristics and therapeutic applications of antimicrobial peptides

    by Olga V. Makhlynets, Gregory A. Caputo

    The demand for novel antimicrobial compounds is rapidly growing due to the phenomenon of antibiotic resistance in bacteria. In response, numerous alternative approaches are being taken including use of polymers, metals, combinatorial approaches, and antimicrobial peptides (AMPs). AMPs are a naturally occurring part of the immune system of all higher organisms and display remarkable broad-spectrum activity and high selectivity for bacterial cells over host cells. However, despite good activity and safety profiles, AMPs have struggled to find success in the clinic. In this review, we outline the fundamental properties of AMPs that make them effective antimicrobials and extend this into three main approaches being used to help AMPs become viable clinical options. These three approaches are the incorporation of non-natural amino acids into the AMP sequence to impart better pharmacological properties, the incorporation of AMPs in hydrogels, and the chemical modification of surfaces with AMPs for device applications. These approaches are being developed to enhance the biocompatibility, stability, and/or bioavailability of AMPs as clinical options.